171 related articles for article (PubMed ID: 1660674)
1. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Am J Hematol; 1991 Dec; 38(4):281-7. PubMed ID: 1660674
[TBL] [Abstract][Full Text] [Related]
2. Changes in plasma levels of tissue-plasminogen activator/inhibitor complex and active plasminogen activator inhibitor in patients with disseminated intravascular coagulation.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Am J Hematol; 1991 Mar; 36(3):176-83. PubMed ID: 1899963
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
Watanabe R; Wada H; Miura Y; Murata Y; Watanabe Y; Sakakura M; Okugawa Y; Nakasaki T; Mori Y; Nishikawa M; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2001 Jul; 7(3):229-33. PubMed ID: 11441985
[TBL] [Abstract][Full Text] [Related]
4. Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.
Wada T; Gando S; Mizugaki A; Yanagida Y; Jesmin S; Yokota H; Ieko M
Thromb Res; 2013 Jul; 132(1):e64-9. PubMed ID: 23726093
[TBL] [Abstract][Full Text] [Related]
5. Role of endothelin in disseminated intravascular coagulation.
Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Matsuda T
Am J Hematol; 1992 Oct; 41(2):71-5. PubMed ID: 1415185
[TBL] [Abstract][Full Text] [Related]
6. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation.
Wada H; Ohiwa M; Kaneko T; Tamaki S; Tanigawa M; Shirakawa S; Koyama M; Hayashi T; Suzuki K
Am J Hematol; 1992 Jan; 39(1):20-4. PubMed ID: 1311143
[TBL] [Abstract][Full Text] [Related]
7. An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.
Asakura H; Ontachi Y; Mizutani T; Kato M; Saito M; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Nakao S
Crit Care Med; 2001 Jun; 29(6):1164-8. PubMed ID: 11395595
[TBL] [Abstract][Full Text] [Related]
8. Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: role of neutrophil elastase.
Gando S; Nakanishi Y; Kameue T; Nanzaki S
J Trauma; 1995 Oct; 39(4):660-4. PubMed ID: 7473950
[TBL] [Abstract][Full Text] [Related]
9. Plasma sFas and sFas ligand levels in patients with thrombotic thrombocytopenic purpura and in those with disseminated intravascular coagulation.
Hori Y; Wada H; Mori Y; Shimura M; Hiyoyama K; Nakasaki T; Nishii K; Tamaki S; Nishikawa M; Deguchi K; Minami N; Shiku H
Am J Hematol; 1999 May; 61(1):21-5. PubMed ID: 10331507
[TBL] [Abstract][Full Text] [Related]
10. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.
Lin SM; Wang YM; Lin HC; Lee KY; Huang CD; Liu CY; Wang CH; Kuo HP
Crit Care Med; 2008 Mar; 36(3):683-9. PubMed ID: 18431261
[TBL] [Abstract][Full Text] [Related]
11. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation.
Wada H; Minamikawa K; Wakita Y; Nakase T; Kaneko T; Ohiwa M; Tamaki S; Deguchi K; Shirakawa S; Hayashi T
Am J Hematol; 1993 Oct; 44(2):85-8. PubMed ID: 8266924
[TBL] [Abstract][Full Text] [Related]
12. A prospective analysis of disseminated intravascular coagulation in patients with infections.
Seki Y; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Kushimoto S; Hatada T; Matsumoto T; Imai H;
Intern Med; 2013; 52(17):1893-8. PubMed ID: 23994978
[TBL] [Abstract][Full Text] [Related]
13. The dynamics of angiogenic factors and their soluble receptors in relation to organ dysfunction in disseminated intravascular coagulation associated with sepsis.
Jesmin S; Wada T; Gando S; Sultana SS; Zaedi S
Inflammation; 2013 Feb; 36(1):186-96. PubMed ID: 22923022
[TBL] [Abstract][Full Text] [Related]
14. Identification of soluble thrombomodulin and tissue plasminogen activator-inhibitor complex as biomarkers for prognosis and early evaluation of septic shock and sepsis-induced disseminated intravascular coagulation.
Zhang J; Xue M; Chen Y; Liu C; Kuang Z; Mu S; Wei W; Yin J; Xiang H; Hu Y; Long X; Fang S; Sun S; Wang B; Tong C; Song Z
Ann Palliat Med; 2021 Oct; 10(10):10170-10184. PubMed ID: 34551574
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic strategy of newly developing medicines for disseminated intravascular coagulation--activated protein C and thrombomodulin].
Maruyama I
Nihon Rinsho; 1993 Jan; 51(1):99-106. PubMed ID: 8381887
[TBL] [Abstract][Full Text] [Related]
16. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
Kotajima N; Kanda T; Fukumura Y; Kobayashi I
J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
[TBL] [Abstract][Full Text] [Related]
17. Coagulation/fibrinolysis abnormality and vascular endothelial damage in the pathogenesis of thrombocytopenic multiple organ failure.
Ueno H; Hirasawa H; Oda S; Shiga H; Nakanishi K; Matsuda K
Crit Care Med; 2002 Oct; 30(10):2242-8. PubMed ID: 12394951
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsis-induced disseminated intravascular coagulation.
Madoiwa S; Nunomiya S; Ono T; Shintani Y; Ohmori T; Mimuro J; Sakata Y
Int J Hematol; 2006 Dec; 84(5):398-405. PubMed ID: 17189219
[TBL] [Abstract][Full Text] [Related]
19. A low TAFI activity and insufficient activation of fibrinolysis by both plasmin and neutrophil elastase promote organ dysfunction in disseminated intravascular coagulation associated with sepsis.
Hayakawa M; Sawamura A; Gando S; Jesmin S; Naito S; Ieko M
Thromb Res; 2012 Dec; 130(6):906-13. PubMed ID: 22353215
[TBL] [Abstract][Full Text] [Related]
20. [Peculiar increase of plasma plasminogen activator inhibitor 1 levels in patients with hemophagocytic histiocytosis].
Shimmyozu K; Kadokura N; Itoyama T; Tara M; Maruyama I; Osame M
Rinsho Ketsueki; 1990 Jan; 31(1):127-8. PubMed ID: 2313902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]